AzTrials
AzTrials

GingivitisNCT01236950

Study of an Essential Oil and a Delmopinol Mouthrinse Effect on Dental Plaque Accumulation Index, Gingivitis Index and on Streptococcus Mutans, Lactobacillus, Aerobic and Anaerobic Oral Bacteria Colony Counts.

A study testing Essential oils mouthrinse and Delmopinol mouthrinse in people with Gingivitis and Dental Plaque Accumulation, run by University of Lisbon at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The use of mouthrinses may be of relevance as a complement to daily dental hygiene procedures, especially for patients who do not comply with a proper mechanical removal of dental plaque. Essential oils and delmopinol mouthrinses are effective to reduce dental plaque accumulation and gingivitis. Read more about this study

Who is it for?
Ages 15 years and olderHealthy volunteers can take part
Conditions the study is for
Gingivitis, Dental Plaque Accumulation
What is being tested?
Essential oils mouthrinse and Delmopinol mouthrinse
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 sitePortugal
Study dates
Apr 2007to Sep 2008
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Patient at the dental hygiene clinic of Faculdade de Medicina Dentária
  • Signature of consent form
  • Have, at least, two quadrant with 6 teeth each
  • Gingival Index at baseline less than 3
  • Presence of dental plaque

Who cannot join

  • Use of a mouthrinse
  • Dental Hygiene appointment in the past 6 months
  • Use of antibiotics in teh past 3 months
  • Presence of extensive caries and fractures of teeth

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Faculdade de Medicina Dentária da Universidade de Lisboa

    Lisbon, Lisbon District, 1649-003

Other trials in Portugal

About this study

The use of mouthrinses may be of relevance as a complement to daily dental hygiene procedures, especially for patients who do not comply with a proper mechanical removal of dental plaque. Essential oils and delmopinol mouthrinses are effective to reduce dental plaque accumulation and gingivitis. Also an effect on dental bacteria can be found. The study hypothesis states that there are no differences between the mouthrinses on the reduction of gingivitis and dental plaque accumulation as well on the bacterial counts of Streptococcus mutans, Lactobacillus, aerobic and anaerobic bacteria.

Being tested
Essential oils mouthrinse, Delmopinol mouthrinse
Keywords
Clinical Trial, Prevention Mouthrinse
Medical subject headings
Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Essential oils mouthrinseDrug

    Also called Listerine Cool Mint

    Commercial mouthrinse with manufacturer's use indication

  • Delmopinol mouthrinseDrug

    Also called Decapinol

    Commercial mouthrinse with manufacturer's use indication

Study groups in NCT01236950
Study groupRoleWhat they receive
Delmopinol mouthrinseExperimentalSubjects use the delmopinol mouthrinse
Receives: Drug: Delmopinol mouthrinse
ControlNo interventionSubjects with no use of mouthrinse
Essential oils mouthrinseExperimentalSubjects using the essential oils mouthrinse
Receives: Drug: Essential oils mouthrinse

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Loe & Silness Gingival Index (1963)

    data collected at the begining of the study and two weeks after mouthrinse usage.

    Measured: change from baseline in gingival index at two weeks

  2. Quigley, Hein & Turesky Dental Plaque Index (1970)

    data collected at the begining of the study and two weeks after mouthrinse usage.

    Measured: change from baseline in plaque index at two weeks

Secondary outcomes (3)
  1. Streptococcus mutans CFU

    data collected at the begining of the study and two weeks after mouthrinse usage.

    Measured: change from baseline in CFU counts at two weeks

  2. Lactobacillus CFU

    data collected at the begining of the study and two weeks after mouthrinse usage.

    Measured: change from baseline in CFU counts at two weeks

  3. Aerobic and anaerobic oral bacteria CFU

    data collected at the begining of the study and two weeks after mouthrinse usage.

    Measured: change from baseline in CFU counts at two weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2010 (estimated)
  2. Study startApr 2007
  3. Primary completionApr 2008
  4. Study completionSep 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01236950
Sponsor's protocol ID
9/2006a
Status last verified
Jul 2010
First submitted
8 Nov 2010
Last updated
10 Nov 2010
Results posted
No
Data monitoring committee
No

Publications

  • Abbott DM, Gunsolley JC, Koertge TE, Payne EL. The relative efficacy of 0.1% and 0.2% delmopinol mouthrinses in inhibiting the development of supragingival dental plaque and gingivitis in man. J Periodontol. 1994 May;65(5):437-41. doi: 10.1902/jop.1994.65.5.437.

    PubMed 8046559
  • Addy M, Moran J, Newcombe RG. Meta-analyses of studies of 0.2% delmopinol mouth rinse as an adjunct to gingival health and plaque control measures. J Clin Periodontol. 2007 Jan;34(1):58-65. doi: 10.1111/j.1600-051X.2006.01013.x. Epub 2006 Nov 20.

    PubMed 17116159
  • Baehni PC, Takeuchi Y. Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 2003;9 Suppl 1:23-9. doi: 10.1034/j.1601-0825.9.s1.5.x.

    PubMed 12974527
  • Barnett ML. The rationale for the daily use of an antimicrobial mouthrinse. J Am Dent Assoc. 2006 Nov;137 Suppl:16S-21S. doi: 10.14219/jada.archive.2006.0408.

    PubMed 17035671
  • Fine DH, Furgang D, Barnett ML, Drew C, Steinberg L, Charles CH, Vincent JW. Effect of an essential oil-containing antiseptic mouthrinse on plaque and salivary Streptococcus mutans levels. J Clin Periodontol. 2000 Mar;27(3):157-61. doi: 10.1034/j.1600-051x.2000.027003157.x.

    PubMed 10743861
  • Gordon JM, Lamster IB, Seiger MC. Efficacy of Listerine antiseptic in inhibiting the development of plaque and gingivitis. J Clin Periodontol. 1985 Sep;12(8):697-704. doi: 10.1111/j.1600-051x.1985.tb00941.x.

    PubMed 3902908
  • Ouhayoun JP. Penetrating the plaque biofilm: impact of essential oil mouthwash. J Clin Periodontol. 2003;30 Suppl 5:10-2. doi: 10.1034/j.1600-051x.30.s5.4.x.

    PubMed 12787196

Questions about this trial

What is this clinical trial studying?

A study testing Essential oils mouthrinse and Delmopinol mouthrinse in people with Gingivitis and Dental Plaque Accumulation, run by University of Lisbon at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Nov 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Loe & Silness Gingival Index (1963) (time frame: change from baseline in gingival index at two weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01236950, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in